ATC code C: Cardiovascular system |
---|
|
Other ATC codes |
|
ATC code C Cardiovascular system is a section of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3][4]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QC.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
Major chemical drug groups – based upon the Anatomical Therapeutic Chemical Classification System
| |
---|---|
gastrointestinal tract / metabolism (A) |
|
blood and blood forming organs (B) |
|
cardiovascular system (C) |
|
skin (D) |
|
genitourinary system (G) |
|
endocrine system (H) |
|
infections and infestations (J, P, QI) |
|
malignant disease (L01–L02) |
|
immune disease (L03–L04) |
|
muscles, bones, and joints (M) |
|
brain and nervous system (N) |
|
respiratory system (R) |
|
sensory organs (S) |
|
other ATC (V) |
|
|
| |||||||
---|---|---|---|---|---|---|---|
Bufadienolides |
| ||||||
Cardenolides |
| ||||||
|
| |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Channel blockers |
| ||||||||||||
Receptor agonists and antagonists |
| ||||||||||||
Ion transporters |
| ||||||||||||
|
Cardiac stimulants excluding cardiac glycosides (C01C)
| |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adrenergic and dopaminergic agents |
| ||||||||||||||
Phosphodiesterase inhibitors (PDE3I) |
| ||||||||||||||
Other cardiac stimulants |
| ||||||||||||||
|
| |
---|---|
Nitrovasodilators |
|
Quinolone vasodilators |
|
Others |
|
|
| |||||
---|---|---|---|---|---|
Sympatholytics (antagonize α-adrenergic vasoconstriction) |
| ||||
Other antagonists |
| ||||
|
| |
---|---|
Nitrovasodilator (arterioles and venules) |
|
Hydrazinophthalazines (arterioles) |
|
Potassium channel openers (arterioles) |
|
Calcium channel blockers (arterioles) |
|
|
| |||||||||
---|---|---|---|---|---|---|---|---|---|
Sulfonamides (and etacrynic acid) |
| ||||||||
Potassium-sparing (atCD) |
| ||||||||
Osmotic diuretics (PT, DL) |
| ||||||||
Vasopressin receptor inhibitors (DCT and CD) |
| ||||||||
Other |
| ||||||||
Combination products |
| ||||||||
|
| |
---|---|
Phenylethanolamine derivatives |
|
Alpha blockers |
|
Niacin and derivatives |
|
Purine derivatives |
|
Ergot alkaloids |
|
Other peripheral vasodilators |
|
| |||||||
---|---|---|---|---|---|---|---|
Antihemorrhoidals for topical use |
| ||||||
Antivaricose therapy |
| ||||||
Capillary stabilising agents |
|
| |
---|---|
β, non-selective |
|
β1-selective |
|
β2-selective |
|
α1- + β-selective |
|
|
| |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Calcium |
| ||||||||||||||||||||||||
Potassium |
| ||||||||||||||||||||||||
Sodium |
| ||||||||||||||||||||||||
Chloride |
| ||||||||||||||||||||||||
Others |
| ||||||||||||||||||||||||
See also: Receptor/signaling modulators • Transient receptor potential channel modulators |
| |
---|---|
ACE inhibitors ("-pril") |
|
AIIRAs ("-sartan") |
|
Renin inhibitors ("-kiren") |
|
Dual ACE/NEP inhibitors |
|
Neprilysin inhibitors |
|
|
| |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GI tract |
| ||||||||||||
Liver |
| ||||||||||||
Blood vessels |
| ||||||||||||
Combinations |
| ||||||||||||
Other |
| ||||||||||||
|